D-0507-2024 Class II Terminated
FDA drug recall D-0507-2024 was initiated by American Regent, Inc. on May 13, 2024 and is designated Class II. Reason for recall: Subpotent product in addition to having out-of-specification results for impurities. The recall status is terminated (terminated Dec 22, 2025). Affected quantity: 2,352 vials.
Recall details
- Product Type
- Drugs
- Report Date
- May 29, 2024
- Initiation Date
- May 13, 2024
- Termination Date
- Dec 22, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,352 vials
Product description
Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01
Reason for recall
Subpotent product in addition to having out-of-specification results for impurities.
Distribution pattern
USA Nationwide
Code information
Lot #: 23061L1C0, Exp 1/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0507-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026